Nobel Prize in Chemistry 2012

  • Author: ChemViews
  • Published Date: 10 October 2012
  • Source / Publisher: NobelPrize.org
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Nobel Prize in Chemistry 2012

The Nobel Prize in Chemistry for 2012 has been awarded to Robert Lefkowitz (left), Howard Hughes Medical Institute, Duke University, USA, and Brian Kobilka (right), Stanford University, USA, for their work on G-protein-coupled receptors (GPCRs).


GPCRs are members of the family of integral membrane proteins (IMPs), which mediate the transfer of material and signals between the environment and the cytoplasm. There are about 1,000 GPCRs in the human body, all of which have similar molecular structures, defined by an amino acid sequence which crosses the plasma membrane seven times. This similarity means GPCRs can be effectively targeted and today as many as 30–50 % of all prescription drugs are designed to "fit" these structures. This has led to new anti-histamines, ulcer drugs, and beta blockers that help relieve hypertension, angina, and coronary disease.


Robert Lefkowitz, Nobel Prize Laureate Chemistry 2012Robert Lefkowitz studied at Columbia College, USA, and gained his M.D. from Columbia University College of Physicians and Surgeons in 1966. He served his internship and residency at the College of Physicians and Surgeons before joining the US National Institutes of Health in1968. He completed his medical residency and research and clinical training in cardiovascular disease at the Massachusetts General Hospital, Boston, USA, from 1970–1973. In 1973 he joined the faculty at the Duke University Medical Center, USA. In 1977 he was promoted to Professor of Medicine and in 1982 to James B. Duke Professor of Medicine at Duke University.

Lefkowitz' research focuses on the detailed characterization of the sequence, structure, and function of GPCRs, particularly the β-adrenergic and related receptors, and the two families of proteins which regulate them, the G-protein-coupled receptor kinases (GRKs) and β-arrestins. He discovered the similarity of the GPCRs' structures through first cloning the gene for the β-adrenergic receptor and later the genes for eight adrenergic receptors for adrenaline and noradrenaline.


Brian Kobilka, Nobel Prize Laureate Chemistry 2012Brian Kobilka studied biology and chemistry at the University of Minnesota, USA. He earned his M.D. from Yale University School of Medicine, USA, which was followed by a residency in internal medicine at Washington University School of Medicine, Barnes Hospital, USA. He was a postdoctoral researcher in the group of Robert Lefkowitz at Duke University, USA, where he started work on cloning the β2-adrenergic receptor. Kobilka moved to Stanford University, USA, in 1989, where he is currently Professor in the departments of Molecular and Cellular Physiology and Medicine.

Kobilka's research focuses on the structure and activity of GPCRs, in particular, determining the molecular structure of the β2-adrenergic receptor. He has developed direct methods to monitor ligand-induced conformational changes in purified β2-adrenergic receptor, and has obtained a high-resolution crystal structure of this receptor.


Papers by Robert Lefkowitz:


Book Chapters by Robert Lefkowitz:


Papers by Brain Kobilka:


Also of interest:

Article Views: 7631

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on facebook

ChemistryViews.org on twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for free newsletter



A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH